NCT03164356View on ClinicalTrials.gov

Bioimpedance as a Diagnostic Tool for Assessing the Need for Socket Modification in Transtibial Amputees

NACompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

November 9, 2016

Primary Completion Date

September 14, 2020

Study Completion Date

December 23, 2020

Conditions
Transtibial Amputee
Interventions
DEVICE

Bioimpedance monitor

Participant in aim 1 will be monitored using the bioimpedance monitor. Data obtained from the arm 1 cohort will be used to inform socket modifications made for arm 2 cohort.

Trial Locations (1)

98105

University of Washington Bioengineering, Seattle

All Listed Sponsors
lead

University of Washington

OTHER

NCT03164356 - Bioimpedance as a Diagnostic Tool for Assessing the Need for Socket Modification in Transtibial Amputees | Biotech Hunter | Biotech Hunter